Oral medications in the isoxazoline class, including fluralaner, afoxolaner, sarolaner, and lotilaner, are the most effective treatments available for killing mange mites on dogs. These chewable tablets can eliminate mites within weeks, with studies showing greater than 99 percent reductions in mite counts after just one or two monthly doses. But the right treatment depends on which type of mange your dog actually has, and the mites themselves are only part of the problem.
Two Different Diseases Under One Name
When people say “mange,” they could mean one of two very different conditions. Sarcoptic mange is caused by Sarcoptes scabiei, a burrowing mite that tunnels into the outer layer of a dog’s skin and triggers intense, relentless itching.1Parasites & Vectors. A review of Sarcoptes scabiei: past, present and future Demodectic mange, on the other hand, comes from Demodex mites that already live on most dogs in small numbers but cause disease only when they multiply out of control.2PubMed Central. Localized demodicosis associated with Demodex canis and Demodex cornei infestation in a dog from Mexico The distinction matters for treatment, prognosis, and whether anyone else in the household is at risk.
Sarcoptic mange is highly contagious. Dogs pick it up through direct contact with an infested animal or contaminated bedding, and the itching is immediate and severe because the dog’s immune system reacts strongly to the mites and their waste products. Demodectic mange is not contagious in the usual sense. Puppies acquire Demodex mites from their mothers in the first days of life, and the mites cause no harm unless the dog’s immune system fails to keep them in check. When it does fail, the mites proliferate, causing patchy hair loss that can progress to widespread skin disease with secondary bacterial infections.
Isoxazoline Chewables Changed the Game
Before the isoxazoline drugs arrived in the mid-2010s, mange treatment often involved messy dips, injectable medications with breed-specific safety concerns, or off-label use of heartworm preventives at high doses. The isoxazolines simplified things dramatically. These drugs work by blocking chloride channels in mite nerve cells, causing paralysis and death. Because dogs absorb the drug into their bloodstream, any mite feeding on the dog gets a lethal dose.
For demodectic mange, the results have been striking. In one study, a single oral dose of fluralaner (the active ingredient in Bravecto) reduced Demodex mite counts by about 99 percent within four weeks, and no live mites could be found on any treated dog by eight weeks.3PubMed Central. Efficacy of oral fluralaner for the treatment of canine generalized demodicosis: a molecular-level confirmation A trial comparing a monthly fluralaner chewable to a topical imidacloprid-moxidectin product found that every dog in the fluralaner group achieved complete parasitological cure by eight weeks, compared to only a quarter of dogs on the topical product.4PubMed Central. Efficacy of a novel 5.46% w/w fluralaner chewable tablet formulation (Bravecto 1-Month) in the treatment of dogs with generalized demodicosis Lotilaner (Credelio) showed similar performance: nine of ten dogs were completely mite-free from day 28 through the end of the study at day 84, and all dogs showed clear hair regrowth by six weeks.5PubMed Central. Efficacy of lotilaner (Credelio™), a novel oral isoxazoline against naturally occurring mange mite infestations in dogs caused by Demodex spp.
The isoxazolines work just as well against sarcoptic mange. A field study of afoxolaner (NexGard) across Portugal and Germany found that two monthly doses eliminated live Sarcoptes mites in all or nearly all treated dogs, with greater than 99 percent reductions in mite counts.6Parasite. Treatment of canine sarcoptic mange with afoxolaner (NexGard) and afoxolaner plus milbemycin oxime (NexGard Spectra) chewable tablets: efficacy under field conditions in Portugal and Germany Sarolaner (Simparica) achieved 100 percent reduction in Sarcoptes mites after two monthly treatments in a lab study, with parallel improvements in hair loss, redness, and crusting.7PubMed. Efficacy and safety of a novel oral isoxazoline, sarolaner (Simparica), for the treatment of sarcoptic mange in dogs A combination product containing sarolaner, moxidectin, and pyrantel (Simparica Trio) reached 100 percent parasitological cure by day 60 in a large-scale field trial.8PubMed Central. Efficacy of a chewable tablet containing sarolaner, moxidectin, and pyrantel (Simparica Trio) in the treatment of sarcoptic mange caused by Sarcoptes scabiei mite infestations in dogs
What makes these drugs particularly appealing is practicality. Giving a flavored chewable tablet is easier than wrestling a dog into a medicated dip every week, and there is no need for gloves, ventilation, or special mixing. For dogs that are already stressed and itchy, a calm oral treatment is a meaningful quality-of-life advantage.
Older Drugs That Still Have a Role
Macrocyclic lactones, a broader class of antiparasitic drugs that includes ivermectin, moxidectin, selamectin, and milbemycin oxime, can also cure both types of mange. A systematic review found that afoxolaner, fluralaner, and sarolaner as well as several macrocyclic lactones including selamectin, moxidectin, and milbemycin oxime all achieved parasitological and clinical cure for sarcoptic mange.9PubMed Central. The most effective systemic treatment in dogs with sarcoptic mange: a critically appraised topic Selamectin is the active ingredient in Revolution, a topical product many owners already use for heartworm and flea prevention. Moxidectin combined with imidacloprid (Advocate/Advantage Multi) has also been widely used for both sarcoptic and demodectic mange.
Ivermectin, once the workhorse drug for treating demodectic mange, is effective but carries a well-known breed-specific danger. Certain breeds, especially Collies, carry a deletion mutation in a gene called ABCB1 (also known as MDR1). This gene normally produces a protein that acts as a pump at the blood-brain barrier, keeping drugs like ivermectin out of the brain. Dogs homozygous for the deletion cannot produce this protein, so ivermectin crosses into the brain and causes severe neurological toxicity, sometimes fatal.10PubMed. Ivermectin sensitivity in collies is associated with a deletion mutation of the mdr1 gene The mutation is not limited to rough and smooth Collies; it has been found at varying frequencies in Shetland Sheepdogs, Australian Shepherds, Old English Sheepdogs, and other herding breeds.11PubMed Central. Association Between the nt230(del4) Mutation and c.-6-180T>G Polymorphism in the Canine ABCB1 Gene Additional mutations beyond the classic four-base-pair deletion have also been reported in individual Border Collies.12PubMed Central. Novel insertion mutation of ABCB1 gene in an ivermectin-sensitive Border Collie
Genetic testing for the ABCB1 mutation is available through simple cheek-swab kits, and many veterinarians now consider it standard before prescribing ivermectin at the higher doses used for mange. The isoxazolines do not share this breed sensitivity, which is one of the main reasons they have largely replaced ivermectin as a first-line treatment for canine mange.
Topical amitraz-based products, applied as dips or spot-on formulations, were once a standard treatment for demodectic mange. A combination of metaflumizone plus amitraz applied every two weeks reduced adult Demodex mites by about 94 percent within four weeks in one case study.13PubMed Central. Efficacy of Amitraz plus Metaflumizone for the treatment of canine demodicosis associated with Malassezia pachydermatis For sarcoptic mange, monthly or biweekly applications of the same formulation achieved cure rates of 75 to 83 percent by day 56.14PubMed. Efficacy of a novel formulation of metaflumizone plus amitraz for the treatment of sarcoptic mange in dogs These numbers are respectable, but noticeably lower than what the isoxazolines deliver, and the application process is more labor-intensive. Amitraz dips also have safety concerns for diabetic dogs and can cause sedation or low blood pressure in the treated animal. They remain available but have been largely eclipsed.
Dealing With the Itch and Skin Infections
Killing the mites is only half the battle, especially with sarcoptic mange. The itching from sarcoptic mange can be so severe that dogs scratch themselves raw, losing sleep and refusing food. Even after an effective acaricide starts killing mites, the itch can persist for days to weeks because the dog’s immune system is still reacting to mite proteins and waste left behind in the skin.
A study of dogs treated with standard antiparasitic drugs for sarcoptic mange found that adding oclacitinib (Apoquel), a drug that blocks itch-related signaling pathways, produced a meaningful decrease in scratching within 24 hours.15PubMed. Use of oclacitinib as antipruritic drug during sarcoptic mange infestation treatment Dogs received oclacitinib twice daily for two weeks, then once daily for another two weeks, alongside their mite-killing medication. Your vet may prescribe a similar short course to keep your dog comfortable while the acaricide does its work. Corticosteroids are sometimes used for the same purpose, though they suppress the immune system more broadly, which can be counterproductive if demodectic mange is the diagnosis.
Both types of mange commonly lead to bacterial skin infections. Damaged, inflamed skin loses its barrier function, and opportunistic bacteria, primarily Staphylococcus species, colonize the openings. For surface-level infections confined to the upper skin layers, topical antimicrobial therapy alone is the recommended first approach rather than systemic antibiotics.16PubMed Central. Antimicrobial use guidelines for canine pyoderma by the International Society for Companion Animal Infectious Diseases (ISCAID) Medicated shampoos containing chlorhexidine or benzoyl peroxide are commonly used. Deeper infections with draining tracts or widespread pustules may need oral antibiotics, ideally chosen based on a culture and sensitivity test to avoid contributing to antibiotic resistance.
How Vets Confirm the Diagnosis and Track Progress
Mange is confirmed by finding mites, eggs, or mite waste in skin samples. For demodectic mange, the standard method is a deep skin scraping: a veterinarian squeezes a fold of skin to push mites out of hair follicles, then scrapes the surface with a blade and examines the material under a microscope. Deep skin scrapings are the most reliable technique, detecting mites in nearly 99 percent of cases in one comparison study, versus about 84 percent for hair plucking (trichograms).17Veterinary Dermatology. Sensitivity of deep skin scrapings, hair pluckings and exudate microscopy in the diagnosis of canine demodicosis A separate comparison of three diagnostic methods found skin scraping superior to both trichograms and taping techniques for isolating Demodex mites.18Jurnal Veteriner. The Comparison of Scraping, Trichogram, and Taping Techniques for Diagnosis of Demodicosis in Dog
Sarcoptic mange is harder to confirm microscopically because the mites are fewer in number and burrow deeply. A negative scraping does not rule it out. When scrapings come up empty but clinical signs are strongly suggestive, vets often start treatment on suspicion and watch for improvement, sometimes called a “therapeutic trial.”
For generalized demodectic mange, treatment monitoring follows a specific protocol: skin scrapings should be repeated monthly throughout treatment, and the acaricidal medication should continue for at least four weeks after the second consecutive negative scraping to prevent relapse.19Veterinary Dermatology. Diagnosis and treatment of demodicosis in dogs and cats Stopping treatment as soon as a dog looks better is one of the most common mistakes owners make, and it is a reliable path to relapse. Demodex mites live deep in hair follicles, and a dog that appears clinically normal may still harbor low numbers of mites that can rebound if treatment is withdrawn too early.
Can Your Family Catch It
Sarcoptic mange is zoonotic. Sarcoptes scabiei mites from dogs can burrow into human skin and cause itchy red bumps, usually on the arms, waist, or thighs where skin-to-skin contact with the dog is most likely.20PubMed Central. Sarcoptic mange: a zoonotic ectoparasitic skin disease In one reported outbreak, close contact with an infested pet dog was identified as the main source of human infection.21PubMed. Sarcoptic mange: report of an outbreak in a family and their pet The good news is that canine Sarcoptes mites cannot complete their life cycle on human skin. In most cases, the human rash is self-limiting once the dog is treated and the mite source is removed. Persistent cases have been reported, but they are uncommon.
Demodectic mange, by contrast, is not considered a meaningful zoonotic risk. Demodex canis is adapted to dogs, and the mites do not establish on human hosts. You do not need to isolate a dog with demodicosis from family members.
For sarcoptic mange, washing bedding, blankets, and any fabric the dog has contacted in hot water is a sensible precaution, since mites can survive off a host for a limited time. Treating all dogs in the household simultaneously is also recommended, as Sarcoptes spreads easily between animals even before symptoms appear.
Why Some Dogs Get Demodectic Mange at All
Almost every dog has Demodex mites. They are part of normal skin flora, acquired from the mother during nursing. The reason most dogs never develop disease while a minority develop severe generalized demodicosis comes down to immune function. Research has established that a genetic predisposition exists for juvenile-onset generalized demodicosis, though the exact primary immune defect has not been identified.22PubMed. Immunology and pathogenesis of canine demodicosis Once mite numbers get high enough, the dog’s immune system appears to enter a state resembling T-cell exhaustion, producing signals that promote tolerance rather than attack. This creates a vicious cycle: the failing immune response allows more mite proliferation, which further suppresses immunity.
Gene expression studies in dogs with demodicosis have found that the immune environment around the mites is skewed toward tolerance. Regulatory pathways that normally dial down immune reactions are strongly activated, while the pathways responsible for allergic-type inflammation are suppressed.23Veterinary Parasitology. Gene expression analysis of Canine Demodicosis; A milieu promoting immune tolerance In practical terms, this means that simply killing the mites with a drug may not be the whole story for some dogs. If the underlying immune suppression persists, whether from genetics, concurrent illness, chemotherapy, or high-dose steroid use, the mites can return after treatment stops.
This is also why veterinary dermatologists generally recommend against breeding dogs that have had generalized demodectic mange. The immune vulnerability appears heritable, and affected dogs can pass the predisposition to offspring. Localized demodicosis in a young puppy, limited to a few small bald patches, often resolves on its own as the immune system matures, and does not necessarily indicate the same genetic risk.
Choosing Between Treatments When Multiple Options Exist
With several isoxazolines on the market along with macrocyclic lactones and topical options, the practical question for many owners is which product to pick. The honest answer is that the isoxazolines perform so similarly to each other that head-to-head differences are small. Systematic reviews of sarcoptic mange treatments have noted that afoxolaner, fluralaner, and sarolaner all achieve parasitological and clinical cure, and that the similarity in their efficacy makes it difficult to single out a clear winner without more comparative trials.9PubMed Central. The most effective systemic treatment in dogs with sarcoptic mange: a critically appraised topic The choice often comes down to which product your dog is already taking for flea and tick prevention, your veterinarian’s familiarity with a given product, and dosing convenience. Fluralaner has a longer duration of action per dose (up to 12 weeks in its original formulation), while afoxolaner, sarolaner, and lotilaner are dosed monthly.
Cost can vary by region and by the dog’s weight class, but all four isoxazolines are prescription medications that sit in a roughly comparable price range for most dog sizes. The larger cost factor for many owners is the total duration of treatment. Sarcoptic mange usually clears with two to three monthly doses. Generalized demodectic mange can require three to six months or more of treatment, with those repeated monthly vet visits for skin scrapings adding up. Starting treatment early, before the infection becomes generalized and secondary infections take hold, keeps both the duration and the total bill shorter.
One factor that does meaningfully differentiate the options is the ABCB1 mutation issue. If you have a herding breed or a mixed-breed dog of unknown genetic background, the isoxazolines sidestep the entire ivermectin-sensitivity concern. For owners who want to use a macrocyclic lactone and have a breed at risk, genetic testing before treatment is strongly recommended.